Investors / United States / Vida Ventures
Vida Ventures
Venture capital · Los Angeles, CA, United States · North America
Vida Ventures is a life sciences investment firm founded by scientists, physicians, entrepreneurs and investors. It builds and backs biomedical companies across therapeutic areas and stages, from de novo start-ups to commercial-stage enterprises.
Invests inHealthcare & Biotech
In its own wordslife sciencesbiomedicinetherapeuticsbiotechhealthcare
Your fit with Vida Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsVida Ventures lists 25 checked portfolio companies on its own site and is named in 7 funding rounds, 1 of them as lead. Its most frequent entry is Series B, 43% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 95% of its companies are based in United States. It invests most often alongside RA Capital, MPM BioImpact and Nextech Invest.
Counts come from funding rounds that name Vida Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Vida Ventures' whole history. Rounds on record name 7 companies; its own site lists 25. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundVida Ventures does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 29% |
| Series B | 43% |
| Growth | 29% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 3 | 0 |
| '26 | 4 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 60th | 25 companies |
| Recent activity | 86th | 5 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 92th | 20% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 42th | 2 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| RA Capital | 5 |
| MPM BioImpact | 4 |
| Nextech Invest | 4 |
| Foresite Capital | 3 |
| Sanofi Ventures | 3 |
| ARCH Venture Partners | 2 |
| Andreessen Horowitz | 2 |
| Atlas Venture | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers2496%
- No longer answers00%
- Points to another company14%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherCompare Vida Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
from public registers and its siteRecent portfolio activity
when companies last raised with Vida Ventures| Date | Company | Stage |
|---|---|---|
| 12 Aug 2026 | Series B | |
| 10 Jun 2026 | Series B Led | |
| 14 Apr 2026 | Series C+ | |
| 7 Jan 2026 | Series A | |
| 1 Dec 2025 | Series B | |
| 7 Oct 2025 | Series A | |
| 15 Apr 2025 | Series C+ |
Round details for Vida Ventures
Amounts, full round histories and every co-investor in Vida Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
25 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| A2 Biotherapeutics is developing cell therapies, including CAR T-cell therapies, to treat solid tumors and other diseases. | Healthcare & Biotech | Portfolio page | ||
| Adcendo is developing a new generation of antibody-drug conjugates to address cancers with high unmet medical need. | Healthcare & Biotech | Apr 2026Series C+ | Page + round | |
| Aktis Oncology develops targeted alpha-based radiopharmaceuticals for the treatment of cancer patients. | Healthcare & Biotech | Portfolio page | ||
| Allogene Therapeutics develops cell therapies, including CAR T treatments, for cancer and autoimmune diseases. | Healthcare & Biotech | Portfolio page | ||
| Alterome Therapeutics is a clinical-stage precision oncology company that develops therapies for cancer treatments. | Healthcare & Biotech | Portfolio page | ||
| Antares Therapeutics develops precision medicines for patients | Healthcare & Biotech | Portfolio page | ||
| Attovia Therapeutics is developing next-generation biotherapeutics for immune-mediated diseases. | Healthcare & Biotech | Apr 2025Series C+ | Page + round | |
| Avalyn Pharma develops inhaled therapies to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases. | Healthcare & Biotech | Portfolio page | ||
| Centessa Pharmaceuticals develops and pursues medicines for patients with various disorders, including sleep-wake, neurological, neurodegenerative and neuropsychiatric disorders. | Healthcare & Biotech | Portfolio page | ||
| Dyne Therapeutics develops nucleic acid therapies for rare diseases. | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| InduPro develops proximity-based therapeutics by manipulating protein interactions on the cell surface to treat diseases. | Healthcare & Biotech | Aug 2026Series B | Page + round | |
| Kyverna Therapeutics develops cell therapies for autoimmune diseases | Healthcare & Biotech | Portfolio page | ||
| LB Pharmaceuticals is developing medicines for brain disorders | Healthcare & Biotech | Portfolio page | ||
| Peloton Therapeutics is a clinical stage pharmaceutical company that develops medicines for patients with cancer and other debilitating or life-threatening conditions. | Healthcare & Biotech | Portfolio page | ||
| Poplar Therapeutics creates anti-IgE medicines | Healthcare & Biotech | Jan 2026Series A | Page + round | |
| Precision Medicine Group helps pharmaceutical and life-sciences clients with product development and commercialization challenges | Healthcare & Biotech | Portfolio page | ||
| Protego Bio is a clinical-stage biotechnology company developing small molecule therapies for protein misfolding diseases, including AL amyloidosis. | Healthcare & Biotech | Dec 2025Series B | Funding round | |
| Quanta Therapeutics develops small molecule inhibitors for RAS-driven cancers | Healthcare & Biotech | Portfolio page | ||
| ReCode Therapeutics develops therapeutics for genetically defined diseases with a focus on cystic fibrosis. | Healthcare & Biotech | Portfolio page |
About this data
site last read 11 Nov 2026- Site
- vidaventures.com
- Last read
- 11 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 15 Apr 2025
- Companies checked
- 25
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Vida Ventures' profile as data
Pull Vida Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/vidaventures.com
# also
GET /v1/firms/vidaventures.com/portfolio
GET /v1/firms/vidaventures.com/coinvestors
GET /v1/firms/vidaventures.com/news